Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7734656

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-04-01 to
2016-06-30
As at
2016-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
90,638,000 JPY
529,612,000 JPY
193,142,000 JPY
Ordinary profit (loss)
-262,140,000 JPY
-1,116,556,000 JPY
-190,499,000 JPY
Profit (loss)
-190,923,000 JPY
Net assets
4,947,694,000 JPY
5,201,149,000 JPY
3,768,596,000 JPY
Total assets
5,099,490,000 JPY
5,408,300,000 JPY
3,922,711,000 JPY
Basic earnings (loss) per share
-7.08
-32.74
-5.97
Diluted earnings per share
Equity-to-asset ratio
0.964 xbrli:pure
0.958 xbrli:pure
0.952 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.